Current Drug Abuse Reviews
Title:Editorial: Second International Conference on Novel Psychoactive Substances (NPSs): Keynote Addresses and Conference Abstracts
Volume: 6 Issue: 4
Author(s): A.C. Parrott, O. Corazza, F. Schifano, P. Griffiths, R. Sedefov, A. Gallegos, R.M. Murray, Z. Demetrovics, V. Curran, G. Bersani and L.T. Singer
Affiliation:
Export Options
About this article
Cite this article as:
Parrott A.C., Corazza O., Schifano F., Griffiths P., Sedefov R., Gallegos A., Murray R.M., Demetrovics Z., Curran V., Bersani G. and Singer L.T., Editorial: Second International Conference on Novel Psychoactive Substances (NPSs): Keynote Addresses and Conference Abstracts, Current Drug Abuse Reviews 2013; 6 (4) . https://dx.doi.org/10.2174/187447370604140616121012
DOI https://dx.doi.org/10.2174/187447370604140616121012 |
Print ISSN 1874-4737 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4745 |
Related Articles
-
Synthesis, Characterization of Some New Five Membered Heterocycles Based on Imidazole Moiety and their Applications on Therapeutics
Letters in Drug Design & Discovery Psychological Perspectives of Inflammatory Bowel Disease Patients Undergoing Surgery: Rightful Concerns and Preconceptions
Current Drug Targets Recent Knowledge on Molecular Components of Lewy Bodies Discloses Future Therapeutic Strategies in Parkinsons Disease
Current Drug Targets - CNS & Neurological Disorders Expanding the Therapeutic Potential of Statins by Means of Nanotechnology Enabled Drug Delivery Systems
Current Topics in Medicinal Chemistry Editorial - Advances of Alzheimers Disease Research: Crossroad of Basic and Translational Studies
Current Alzheimer Research Low Plasma Leptin in Cognitively Impaired ADNI Subjects: Gender Differences and Diagnostic and Therapeutic Potential
Current Alzheimer Research Peptide Self-assembly: From Toxins to Amyloid Fibrils and Nanotubes
Current Topics in Medicinal Chemistry Evolution of Specific Cognitive Subprofiles of Mild Cognitive Impairment in a Three-Year Longitudinal Study
Current Aging Science Editorial (Hot Topic: Flavoproteins and Flavoenzymes with Biomedical and Therapeutic Impact)
Current Pharmaceutical Design Pharmaceutical Interventions for Frailty and Sarcopenia
Current Pharmaceutical Design Recent Progress in the Development of Adenosine Receptor Ligands as Antiinflammatory Drugs
Current Topics in Medicinal Chemistry Sevoflurane But Not Propofol Provided Dual Effects of Cell Survival in Human Neuroblastoma SH-SY5Y Cells
Current Alzheimer Research Update of the Preclinical Situation of Anticancer Platinum Complexes: Novel Design Strategies and Innovative Analytical Approaches
Current Medicinal Chemistry Recent Gains in Clinical Multiple Sclerosis Research
CNS & Neurological Disorders - Drug Targets Determinants of Smoking Cessation Attempts Among HIV-Infected Patients: Results from a Hospital-Based Prospective Cohort
Current HIV Research Therapeutic Strategy of Targeting Astrocytes for Neuroprotection in Parkinson's Disease
Current Pharmaceutical Design Innate Immunity and the Heart
Current Pharmaceutical Design Apo-E4 Allele in Conjunction with Aβ42 and Tau in CSF: Biomarker for Alzheimers Disease
Current Alzheimer Research Mitochondria Play a Central Role in Estrogen-Induced Neuroprotection
Current Drug Targets - CNS & Neurological Disorders Home Environmental Control for Children with Asthma
Current Pediatric Reviews